Literature DB >> 2443081

Lindane neurotoxic reaction in nonbullous congenital ichthyosiform erythroderma.

S J Friedman.   

Abstract

A 3-year-old boy with nonbullous congenital ichthyosiform erythroderma with a four-month history of scabies was treated with a single dose of lindane cream. In a 48-hour period, he developed nausea and vomiting and also suffered from an epileptiform convulsion and muscular spasms. Seventy-two hours after application of the cream, his blood lindane level was 54 ng/mL. Caution should be exercised when using lindane in patients with compromised epidermal barrier function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443081

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

Review 1.  Pharmacotherapy of ectoparasitic infections.

Authors:  T C Roos; M Alam; S Roos; H F Merk; D R Bickers
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Scabies: more than just an irritation.

Authors:  J S McCarthy; D J Kemp; S F Walton; B J Currie
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

Review 3.  A risk-benefit assessment of agents used in the treatment of scabies.

Authors:  M L Elgart
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

4.  Case report: a new method for treatment of permethrin - resistant head lice.

Authors:  Farhad Jahangiri
Journal:  Clin Case Rep       Date:  2017-03-17

5.  Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

Authors:  Rachel S Meyers; Jennifer Thackray; Kelly L Matson; Christopher McPherson; Lisa Lubsch; Robert C Hellinga; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2020

6.  A chitinase-like protein from Sarcoptes scabiei as a candidate anti-mite vaccine that contributes to immune protection in rabbits.

Authors:  Nengxing Shen; Haojie Zhang; Yongjun Ren; Ran He; Jing Xu; Chunyan Li; Weimin Lai; Xiaobin Gu; Yue Xie; Xuerong Peng; Guangyou Yang
Journal:  Parasit Vectors       Date:  2018-11-20       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.